World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
22228
World Ranking
1398
National Ranking
93

Medicine

D-Index
84
Citations
22229
World Ranking
15258
National Ranking
810

Volker Schirrmacher publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Volker Schirrmacher sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 459 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Volker Schirrmacher D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Volker Schirrmacher sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Volker Schirrmacher is affiliated with the German Cancer Research Center in Germany and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on oncology and immunology, with significant work related to genetics, pulmonary and respiratory medicine, and neurology.

The scientist's key research topics include:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Glioma diagnosis and treatment
  • Immunotherapy and immune responses
  • Cancer immunotherapy and biomarkers
  • Brain metastases and treatment
  • Neuroblastoma research and treatments

Volker Schirrmacher has collaborated frequently with several coauthors, most notably Stefaan Van Gool, Wilfried Stuecker, Jennifer Makalowski, Tobias Sprenger, and Peter Van de Vliet.

The scientist's recent notable publications include:

  • Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications, 2021, Biomedicines
  • Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism, 2020, Biomedicines
  • Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis, 2020, Biomedicines
  • Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus, 2022, Biomedicines
  • Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged, 2020, Cancers

Volker Schirrmacher has published predominantly in journals such as Biomedicines and Neuro-Oncology, with additional articles appearing in the International Journal of Molecular Sciences, Cancers, and Medicines.

Best Publications

  • From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)

    Volker Schirrmacher

  • Bone marrow as a priming site for T-cell responses to blood-borne antigen

    Markus Feuerer;Philipp Beckhove;Natalio Garbi;Yolanda Mahnke

  • THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITY

    Unknown

  • EGF receptor in neoplasia and metastasis.

    Khashayarsha Khazaie;Volker Schirrmacher;Rosemarie B. Lichtner

  • Lymphoma Cell-mediated Degradation of Sulfated Proteoglycans in the Subendothelial Extracellular Matrix: Relationship to Tumor Cell Metastasis

    I. Vlodavsky;Z. Fuks;M. Bar-Ner;Y. Ariav

  • Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

    Markus Feuerer;Philipp Beckhove;Lianhua Bai;Erich Franz Solomayer

  • Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies

    Unknown

  • Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus.

    Ari Helenius;Bror Morein;Erik Fries;Kai Simons

  • Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin

    J. Dennis;C. Waller;R. Timpl;V. Schirrmacher

  • Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

    Orit Goldshmidt;Eyal Zcharia;Rinat Abramovitch;Shula Metzger

  • Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit

    Hans Herbert Steiner;Matteo Mario Bonsanto;Philipp Beckhove;Michael Brysch

  • Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release.

    Alexey Ushmorov;Frank Ratter;Volker Lehmann;Wulf Dröge

  • Different Patterns of Lectin Binding and Cell Surface Sialylation Detected on Related High- and Low-Metastatic Tumor Lines

    Peter Altevogt;Mina Fogel;Rachanee Cheingsong-Popov;Jim Dennis

  • Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

    V. Schirrmacher;G. Shantz;K. Cauer;D. Komitowski

  • Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

    Mostafa Jarahian;Carsten Watzl;Philippe Fournier;Annette Arnold

  • Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.

    V Schirrmacher;C Haas;R Bonifer;T Ahlert

  • Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients

    Markus Feuerer;Marian Rocha;Lianhua Bai;Victor Umansky

  • Further evidence for derepression of h-2 and ia-like specificities of foreign haplotypes in mouse tumour cell lines.

    Federico Garrido;Hilliard Festenstein;Volker Schirrmacher

  • High Frequencies of Functional Tumor-Reactive T Cells in Bone Marrow and Blood of Pancreatic Cancer Patients

    Friedrich H. Schmitz-Winnenthal;Christine Volk;Kaspar Z'graggen;Luis Galindo

  • Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors

    Philipp Beckhove;Markus Feuerer;Mathias Dolenc;Florian Schuetz

  • Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

    D Ockert;V Schirrmacher;N Beck;E Stoelben

  • Tumor selective replication of Newcastle Disease Virus: association with defects of tumor cells in antiviral defence.

    Christoph Fiola;Ben Peeters;Philippe Fournier;Annette Arnold

Frequent Co-Authors

Philipp Beckhove
Philipp Beckhove German Cancer Research Center
Peter Altevogt
Peter Altevogt German Cancer Research Center
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Peter M. Schlag
Peter M. Schlag Charité - University Medicine Berlin
Viktor Umansky
Viktor Umansky Heidelberg University
Israel Vlodavsky
Israel Vlodavsky Technion – Israel Institute of Technology
Jürgen Weitz
Jürgen Weitz TU Dresden
Gerhard Moldenhauer
Gerhard Moldenhauer German Cancer Research Center
Frank Momburg
Frank Momburg German Cancer Research Center
Bruno Kyewski
Bruno Kyewski German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open doors to diverse healthcare and research careers. For those interested in advancing clinical expertise, pursuing a Doctor of Nursing Practice (DNP) degree is a valuable option. Understanding the dnp salary by state helps graduates assess financial prospects across different locations.

Nurses looking to specialize further often consider transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP). This move allows professionals to provide critical care services and expand their skill sets. Helpful insights can be found in guides on how to transition from FNP to ACNP.

For those pursuing faster routes to specialization, enrolling in accelerated np programs online offers flexible pathways to become a nurse practitioner. Additionally, individuals without a nursing background might explore online rn programs for non nurses in florida to start their healthcare journey with convenience and accessibility. These programs exemplify how evolving educational options support diverse student needs within the immunology and healthcare spectrum.

Best Scientists Citing Volker Schirrmacher

Trending Scientists

Recently Published Articles